Q1 2025 Xtant Medical Holdings Inc Earnings Call Transcript
Key Points
- Xtant Medical Holdings Inc (XTNT) reported an 18% increase in revenue for Q1 2025, reaching $32.9 million.
- The company achieved strong adjusted EBITDA and positive net income, marking a significant financial improvement.
- Xtant completed the full vertical integration of its biologics products, enhancing operational efficiency and cost savings.
- The launch of new products, Trivium and FibreX, is expected to drive growth and offset product rationalization impacts.
- The termination of a restrictive investor rights agreement with OrbiMed opens new strategic opportunities for Xtant.
- Gross margin decreased slightly to 61.5% from 62.1% due to inventory disposal charges and provisions for excess inventory.
- Spinal implant sales declined by 10% year-over-year, impacting overall revenue growth.
- The company remains cautious about potential changes in CMS policy, which could affect future royalty income.
- Operating expenses, although reduced, still represent a significant portion of total revenue at 58.3%.
- The company anticipates flat to modestly declining hardware revenue for the fiscal year 2025.
Good afternoon, everyone, and welcome to the Xtant Medical's first quarter 2025 financial results. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Brett Maas of Hayden Investor Relations. Brett, the floor is yours. I will now turn the conference over to your host, Brett Maas of Hayden Investor Relations.
Brett, the floor is yours.
Thank you, operator. Joining me today is Sean Browne, President and Chief Executive Officer; and Scott Neils, Chief Financial Officer. Today's call is being webcast and will be posted on the company's website for playback.
During the course of this call, management may make certain forward-looking statements regarding future events and the company's expected future performance. These forward-looking statements reflect Xtant's current perspective on existing trends and information that can be identified such words as expect, plan, will, may, anticipate, believe, should, intend and other words with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
